Literature DB >> 18425106

Up on the tightrope: natural killer cell activation and inhibition.

Lewis L Lanier1.   

Abstract

Natural killer (NK) cells circulate through the blood, lymphatics and tissues, on patrol for the presence of transformed or pathogen-infected cells. As almost all NK cell receptors bind to host-encoded ligands, signals are constantly being transmitted into NK cells, whether they interact with normal or abnormal cells. The sophisticated repertoire of activating and inhibitory receptors that has evolved to regulate NK cell activity ensures that NK cells protect hosts against pathogens, yet prevents deleterious NK cell-driven autoimmune responses. Here I highlight recent advances in our understanding of the structural properties and signaling pathways of the inhibitory and activating NK cell receptors, with a particular focus on the ITAM-dependent activating receptors, the NKG2D-DAP10 receptor complexes and the CD244 receptor system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425106      PMCID: PMC2669298          DOI: 10.1038/ni1581

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  78 in total

1.  Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases.

Authors:  Francesco Colucci; Edina Schweighoffer; Elena Tomasello; Martin Turner; John R Ortaldo; Eric Vivier; Victor L J Tybulewicz; James P Di Santo
Journal:  Nat Immunol       Date:  2002-02-11       Impact factor: 25.606

2.  2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function.

Authors:  Jennifer Klem; Pamela C Verrett; Vinay Kumar; John D Schatzle
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

3.  NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.

Authors:  Simona Zompi; Jessica A Hamerman; Kouetsu Ogasawara; Edina Schweighoffer; Victor L J Tybulewicz; James P Di Santo; Lewis L Lanier; Francesco Colucci
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

4.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

Authors:  Amanda M Jamieson; Andreas Diefenbach; Christopher W McMahon; Na Xiong; James R Carlyle; David H Raulet
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

5.  NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.

Authors:  Susan Gilfillan; Emily L Ho; Marina Cella; Wayne M Yokoyama; Marco Colonna
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

6.  Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.

Authors:  Andreas Diefenbach; Elena Tomasello; Mathias Lucas; Amanda M Jamieson; Jennifer K Hsia; Eric Vivier; David H Raulet
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

7.  Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.

Authors:  Ala Aoukaty; Rusung Tan
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

8.  NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.

Authors:  Daniel D Billadeau; Jadee L Upshaw; Renee A Schoon; Christopher J Dick; Paul J Leibson
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

9.  SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells.

Authors:  Ricciarda Galandrini; Ilaria Tassi; Gianfranco Mattia; Luisa Lenti; Mario Piccoli; Luigi Frati; Angela Santoni
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts.

Authors:  Carsten Watzl; Eric O Long
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  689 in total

1.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

3.  Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Authors:  Joo Chun Yoon; Jong-Baeck Lim; Jeon Han Park; Jae Myun Lee
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

4.  NKG2C deletion is a risk factor of HIV infection.

Authors:  Rachel Thomas; Hui Zhi Low; Katja Kniesch; Roland Jacobs; Reinhold E Schmidt; Torsten Witte
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-03       Impact factor: 2.205

5.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

6.  Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.

Authors:  E Liu; Y Tong; G Dotti; H Shaim; B Savoldo; M Mukherjee; J Orange; X Wan; X Lu; A Reynolds; M Gagea; P Banerjee; R Cai; M H Bdaiwi; R Basar; M Muftuoglu; L Li; D Marin; W Wierda; M Keating; R Champlin; E Shpall; K Rezvani
Journal:  Leukemia       Date:  2017-07-20       Impact factor: 11.528

7.  MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.

Authors:  Amanda R Campbell; Megan C Duggan; Lorena P Suarez-Kelly; Neela Bhave; Kallan S Opheim; Elizabeth L McMichael; Prashant Trikha; Robin Parihar; Eric Luedke; Adrian Lewis; Bryant Yung; Robert Lee; David Raulet; Susheela Tridandapani; Veronika Groh; Lianbo Yu; Vedat Yildiz; John C Byrd; Michael A Caligiuri; William E Carson
Journal:  Cancer Immunol Res       Date:  2017-07-19       Impact factor: 11.151

Review 8.  Memory responses of natural killer cells.

Authors:  Clair D Geary; Joseph C Sun
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

Review 9.  CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

Authors:  Joseph D Malaer; Porunelloor A Mathew
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

10.  Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.

Authors:  Raphael Carapito; Ismail Aouadi; Angélique Pichot; Perrine Spinnhirny; Aurore Morlon; Irina Kotova; Cécile Macquin; Véronique Rolli; Anne Cesbron; Katia Gagne; Machteld Oudshoorn; Bronno van der Holt; Myriam Labalette; Eric Spierings; Christophe Picard; Pascale Loiseau; Ryad Tamouza; Antoine Toubert; Anne Parissiadis; Valérie Dubois; Catherine Paillard; Myriam Maumy-Bertrand; Frédéric Bertrand; Peter A von dem Borne; Jürgen H E Kuball; Mauricette Michallet; Bruno Lioure; Régis Peffault de Latour; Didier Blaise; Jan J Cornelissen; Ibrahim Yakoub-Agha; Frans Claas; Philippe Moreau; Dominique Charron; Mohamad Mohty; Yasuo Morishima; Gérard Socié; Seiamak Bahram
Journal:  Bone Marrow Transplant       Date:  2020-04-14       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.